# A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

> **NCT06706622** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **H. Lundbeck A/S** · enrollment: 401 (actual)

## Conditions studied

- Multiple System Atrophy

## Interventions

- **DRUG:** Amlenetug
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06706622
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-03
- **Primary completion:** 2028-02-17
- **Final completion:** 2029-10-25
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06706622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06706622, "A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06706622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*